Murine model to study brain, behavior and immunity during hepatic encephalopathy

Area of Science:

• Hepatology
• Neurology
• Toxicology

Background:

• Hepatic encephalopathy (HE) is a complex neurological complication of liver dysfunction.
• Existing animal models often fail to fully recapitulate the multifaceted clinical manifestations of human HE.
• Developing a robust and relevant preclinical model is crucial for understanding HE pathogenesis and testing therapeutic interventions.

Purpose of the Study:

• To establish and validate a novel murine model of hepatic encephalopathy (HE).
• To ensure the model closely mimics key pathological and clinical features of HE observed in human patients.
• To provide a valuable tool for investigating HE mechanisms and evaluating potential treatments.

Main Methods:

• Mice were administered two low-dose intraperitoneal injections of thioacetamide (TAA).
• Liver injury was assessed via serum ALT levels and histology; neutrophil infiltration by intravital microscopy.
• Neurological function was evaluated using EEG, psychomotor activity, and brain edema assessment via MRI; ammonia levels were quantified.

Main Results:

• TAA treatment induced significant liver necrosis, elevated ALT, and severe coagulopathy.
• Increased serum and brain ammonia levels correlated with EEG alterations and brain edema.
• Mice exhibited neuropsychomotor abnormalities and signs of multiple organ dysfunction, mirroring human HE symptoms.

Conclusions:

• The TAA-induced mouse model effectively replicates critical human hepatic encephalopathy features.
• This model demonstrates liver injury, hyperammonemia, neurological deficits, and multi-organ involvement.
• This novel murine model offers a promising platform for advancing HE research and therapeutic development.